Application segmentation of the Phacoemulsification Tools market distinguishes three primary use‑cases: routine cataract extraction, premium intra‑ocular lens (IOL) implantation, and complex/combined procedures. Routine cataract extraction accounts for the largest share, driven by the high global incidence of age‑related cataracts and the standardized nature of the procedure; it contributes roughly 60 % of total market revenue. Premium IOL implantation, which includes multifocal, toric and extended‑depth‑of‑focus lenses, captures about 25 % of the market, reflecting growing patient demand for reduced dependence on glasses and higher reimbursement rates in developed economies. Complex and combined procedures—such as subluxated lens removal, femtosecond‑laser‑assisted cases, and simultaneous glaucoma surgery—represent the remaining 15 % and are expanding as surgeons adopt advanced techniques. This Phacoemulsification Tools segmentation highlights how each application drives distinct procurement patterns, technology adoption rates, and pricing dynamics, collectively shaping the overall market size. Moreover, regional variations in cataract prevalence and insurance coverage further modulate the revenue contribution of each application segment.
